Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Avastin versus verteporfin PDT in neovascular AMD
2006-001200-36Phase 2Active
- Sponsor
- St. Eriks Eye Hospital
- Start
- Jun 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bevacizumab in exudative macular degeneration (2 arms), sponsored by St. Eriks Eye Hospital. Primary endpoint: Maintenance of visual acuity. Started Jun 2006; status: active.
02
Drugs
bevacizumab
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on 2006-001200-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001200-36.